Handelsavisen
prelaunch
Companies Healthcare YATH.NS
YA
YATH.NS NSE (India) Healthcare Facilities & Services

Yatharth Hospital & Trauma Care Services Ltd

$815,60
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
56,6 %
ROE
4,4 %
Net margin
21,5 %
Debt / equity
0,10
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Yatharth Hospital & Trauma Care Services Ltd operates in the healthcare facilities and services industry, providing hospital and trauma care services to patients, generating revenue primarily through inpatient and outpatient care.

Business. Yatharth Hospital & Trauma Care Services Ltd (YATH.NS) is a healthcare facilities and services company headquartered in India. The firm operates within the Healthcare Services & Equipment sector, providing hospital and trauma care services. It is primarily listed on the National Stock Exchange of India. Specific details regarding operating segments and geographic revenue mix are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
BUY2 analysts
2 buy0 hold0 sell
Avg 12m price target910,00

Analyst recommendations

2 analysts · consensus Buy
Buy2
Hold0
Sell0
12-month price target
910,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
4,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning YATH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to YATH.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Yatharth Hospital & Trauma Care Services Ltd (YATH.NS) is a healthcare facilities and services company headquartered in India. The firm operates within the Healthcare Services & Equipment sector, providing hospital and trauma care services. It is primarily listed on the National Stock Exchange of India. Specific details regarding operating segments and geographic revenue mix are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    Yatharth Hospital & Trauma Care Services Ltd maintains a strong liquidity position, with a current ratio of 7.59, indicating a significant buffer of current assets over current liabilities. The company's liquidity_fpt score is high, supported by cash and equivalents of INR 1,126.96 million, which is a substantial portion of its total assets. This liquidity position is further reinforced by a low debt-to-equity ratio of 0.1, suggesting minimal reliance on debt financing.

    In terms of profitability, the company's return on equity (ROE) of 4.39% and return on assets (ROA) of 3.76% are below the industry median for healthcare facilities and services, indicating that the company is not generating returns as efficiently as its peers. The net income of INR 383.48 million on a revenue of INR 1,779.67 million suggests a net margin of approximately 21.5%, which is relatively strong but not exceptional within the industry.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to regional economic or regulatory risks, although the current risk assessment does not flag this as a high concern.

    Looking ahead, the company is projected to experience moderate growth, with revenue expected to increase in the current fiscal year and the following year. The operating cash flow of INR -30.78 million and capital expenditure of INR -933.65 million indicate that the company is investing in its operations, which could support future growth. However, the negative operating cash flow suggests that the company is currently spending more than it is generating from operations, which may require continued reliance on financing or asset sales.

    The risk assessment indicates a low probability of dilution and no immediate liquidity concerns. The company's capital structure is stable, with a low debt-to-equity ratio and a strong equity base of INR 8,743.23 million. The absence of dilution flags and the low dilution risk suggest that the company is not expected to issue additional shares in the near term, preserving shareholder value.

    Recent filings and transcripts do not indicate any material events that would significantly impact the company's operations or financial position. The company's management has not disclosed any major strategic shifts or regulatory challenges in the latest reports. Analysts have assigned a mean recommendation of 2.00, indicating a "buy" rating, with a mean price target of INR 910.00, suggesting a positive outlook from the investment community.

    Key takeaways
    • Yatharth Hospital & Trauma Care Services Ltd has a strong liquidity position with a current ratio of 7.59 and a low debt-to-equity ratio of 0.1.
    • The company's profitability metrics, including ROE of 4.39% and ROA of 3.76%, are below the industry median, indicating room for improvement in operational efficiency.
    • The company's revenue is concentrated in a single business segment, with no significant geographic diversification reported.
    • Analysts have assigned a "buy" rating to the stock, with a mean price target of INR 910.00, reflecting a positive outlook.
    • The company is investing in its operations, with a capital expenditure of INR -933.65 million, which may support future growth.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 2

    Debt-to-equity ratio of 0.1 is well below the 0.32 sector median, reflecting a strong balance sheet.

    Analysts project 11.6% upside to a mean price target of 910, signaling positive market sentiment.

    BEAR CASE · 2

    Cash conversion of -0.08 ranks in the bottom quartile, far below the 1.35 sector median.

    Return on equity of 4.4% trails the 4.6% sector median, indicating below-average shareholder returns.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-05
    Q4 2025 · Quarter highlights

    Revenue INR 3.20B, +46,2% YoY; Operating income −57,2% YoY.

    RevenueINR 3.20B+46,2 % YoY
    Operating incomeINR 502.9M−57,2 % YoY
    Net incomeINR 453.5M+48,7 % YoY
    Free cash flow
    EPS
    Operating cash flow
    Financials
    Income statement
    RevenueINR 3.20B
    Gross profitINR 2.58B
    Operating incomeINR 502.9M
    Net incomeINR 453.5M
    Margins
    Gross margin80.5%
    Operating margin15.7%
    Net margin14.2%
    FCF margin
    P&L flow · revenue → net income
    Revenue INR 3.20BOperating costs INR 2.70BTax INR 49.4MNet income INR 453.5M
    Highlights
    • Revenue INR 3.20B, +46,2% YoY
    • Operating income −57,2% YoY
    • Net income +48,7% YoY
    • Net margin 14.2%

    Valuation TTM

    Market price
    $815,60
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $8.74B
    Net cash
    $280.5M
    Current ratio
    7.6
    Debt / equity
    0.1
    ROA
    3.8%
    ROE
    4.4%
    Cash conversion
    -8.0%
    CapEx / revenue
    -52.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    17,45
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-16 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate17,45
    Revenueno estimateno estimate12,1B INR
    Operating incomeno estimateno estimate2,3B INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy0
    Buy2
    Hold0
    Sell0
    Strong sell0
    12-month price target$910,00 · Median $910,00
    Low $900,00High $920,00
    Operating income · consensus2,3B INR
    EPS surprise
    −15,6 %
    reported vs consensus · miss
    Revenue surprise
    −27,0 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$900,00
    Mean$910,00
    Median$910,00
    High$920,00
    Spot$815,60
    +11.6 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin56,6 %Best in class
    Net Margin21,6 %Best in class
    ROE4,4 %Below median
    Capex / Rev-52,5 %Bottom quartile
    D/E0,10Above median
    Cash Conv-0,08Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Yatharth Hospital & Trauma Care Services Ltd Market data — financials · 2026-05-30
    • Yatharth Hospital & Trauma Care Services Ltd Market data — analyst estimates · 2026-05-30

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    YATH.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-02-05 14:10 UTCEARNINGSQuarterly results — Q4 2025 Revenue INR 3.20B · Net INR 453.5M
    2025-11-13 14:38 UTCEARNINGSQuarterly results — Q3 2025 Revenue INR 2.79B · Net INR 412.4M
    2025-08-05 14:23 UTCEARNINGSQuarterly results — Q2 2025 Revenue INR 2.58B · Net INR 420.4M
    2025-05-26 18:09 UTCEARNINGSQuarterly results — Q1 2025 Revenue INR 2.32B · Net INR 387.2M
    2025-05-26 18:09 UTCEARNINGSAnnual results — FY 2025 Revenue INR 8.80B · Net INR 1.31B
    2025-01-27 19:05 UTCEARNINGSQuarterly results — Q4 2024 Revenue INR 2.19B · Net INR 304.9M
    2024-11-07 20:13 UTCEARNINGSQuarterly results — Q3 2024 Revenue INR 2.18B · Net INR 309.5M
    2024-08-14 03:45 UTCEARNINGSQuarterly results — Q2 2024 Revenue INR 2.12B · Net INR 303.8M
    2024-05-23 10:35 UTCEARNINGSQuarterly results — Q1 2024 Revenue INR 1.78B · Net INR 383.5M
    2024-05-23 10:35 UTCEARNINGSAnnual results — FY 2024 Revenue INR 6.71B · Net INR 1.14B
    2023-05-29 19:37 UTCEARNINGSAnnual results — FY 2023 Revenue INR 5.20B · Net INR 657.7M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage